berberine has been researched along with Respiratory Distress Syndrome in 3 studies
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) is an isoquinoline alkaloid extracted from Coptis chinensis, a plant used in traditional Chinese medicine that exerts multiple pharmacological effects." | 1.48 | Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS. ( Feng, J; Huang, L; Li, D; Liu, X; Lü, J; Ma, X; Pan, X; Wang, X; Zhang, D; Zhang, X, 2018) |
| "Acute lung injury is still a significant clinical problem having a high mortality rate despite significant advances in antimicrobial therapy and supportive care made in the past few years." | 1.35 | Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice. ( Fu, YM; Lu, DX; Qi, RB; Wang, HD; Wang, YP; Yan, YX; Zhang, HQ, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Babalghith, AO | 1 |
| Al-Kuraishy, HM | 1 |
| Al-Gareeb, AI | 1 |
| De Waard, M | 1 |
| Al-Hamash, SM | 1 |
| Jean-Marc, S | 1 |
| Negm, WA | 1 |
| Batiha, GE | 1 |
| Huang, L | 1 |
| Zhang, X | 1 |
| Ma, X | 1 |
| Zhang, D | 1 |
| Li, D | 1 |
| Feng, J | 1 |
| Pan, X | 1 |
| Lü, J | 1 |
| Wang, X | 1 |
| Liu, X | 1 |
| Zhang, HQ | 1 |
| Wang, HD | 1 |
| Lu, DX | 1 |
| Qi, RB | 1 |
| Wang, YP | 1 |
| Yan, YX | 1 |
| Fu, YM | 1 |
1 review available for berberine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
The role of berberine in Covid-19: potential adjunct therapy.
Topics: Anti-Inflammatory Agents; Antioxidants; Antiviral Agents; Berberine; COVID-19 Drug Treatment; Humans | 2022 |
2 other studies available for berberine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS.
Topics: Animals; Berberine; Cell Survival; Gene Expression Regulation; Glycocalyx; Human Umbilical Vein Endo | 2018 |
Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice.
Topics: Animals; Berberine; Bronchoalveolar Lavage Fluid; Lipopolysaccharides; Lung Injury; Mice; Neutrophil | 2008 |